Psychedelics in the treatment of unipolar mood disorders: a systematic review
Journal of Psychopharmacology November 18, 2016 James Rucker, Luke A. Jelen, Sarah Kalen Flynn et al. 187 citations
Unipolar mood disorders, including major depressive disorder and persistent depressive disorder (dysthymia), confer high rates of disability and mortality and a very high socioeconomic burden. Current treatment is suboptimal in most cases and there is little of note in the pharmaceutical development pipeline. The psychedelic drugs, including lysergic acid diethylamide and psilocybin, were used...